Fatemeh Molaabasi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fatemeh Molaabasi has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
- Mojtaba Shamsipur
Razi University
8 shared publications - Amirhosein Kefayat
Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK
7 shared publications Seyed Morteza Naghib
Nanotechnology Department, School of Advanced Technologies, Iran University of Science and Technology (IUST), Tehran, Iran
5 shared publications- Rahmatollah Rahimi
Department of Chemistry, Iran University of Science and Technology, Tehran, Iran
4 shared publications - Farimah Mousavi
Department of Chemistry
3 shared publications Morteza Sarparast
Department of Chemistry, Razi University, Kermanshah 6714414971, Iran
3 shared publications
Latest Publications
- 26 May 2026
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
Unique Dual-Functional and Label-Free Turn-On and Turn-Off Fluorescence Biosensor to Antibiotics Using Hemoglobin-Capped Platinum Nanoribbons: From Reduction-Induced Emission to Inner Filter Effect and Aggregation-Caused Quenching
Distinct from the predominantly known single-functional biosensor, dual-functional response to antibiotics by luminescent nanoribbons remains largely unexplored despite their interesting advantages in enabling self-validation through two independent fluorescence mechanisms. Antibiotic residues in food and environmental matrices pose serious health risks, which emphasizes the urgent need for highly sensitive and reliable detection strategies. Conventional analytical methods, however, often suffer from biological interferences and labor-intensive procedures, thereby underscoring demand for more efficient and robust alternatives. In this study, we focus on the detection of penicillin G (PG) and ofloxacin (OFL), representative members of the β-lactam and fluoroquinolone classes, respectively. Unlike previous reports that mainly targeted a single antibiotic class, we introduce, for the first time, a dual-functional, label-free, protein-capped platinum nanoribbon (Hb/PtNRBs) sensor capable of detecting PG via a fluorescence turn-off mechanism and OFL through a turn-on mechanism. The one-dimensional (1D) porous Pt nanoribbons, exhibiting intense blue fluorescence, were synthesized based on aggregation-induced emission (AIE) in a green, single-step process using hemoglobin (Hb) as both a reducing and capping agent. The Hb/PtNRBs display blue fluorescence with a peak centered at 442 nm (photoexcited at 325 nm) and a quantum yield of 0.25. PG detection occurs through a combination of the inner filter effect (IFE) and aggregation-caused quenching (ACQ), whereas OFL detection is attributed to a reduction-induced emission (RIE) mechanism. Under the optimized conditions, the sensor exhibited wide linear ranges of 0.2-65 μM for PG (LOD = 60 nM) and 0.2-42 μM for OFL (LOD = 45 nM). Practical applicability was confirmed in real samples, including water, cow milk, and eggs, achieving recoveries of 87.25-106.34% for PG and 86.58-120.18% for OFL. These results highlight the high sensitivity, selectivity, and potential of Hb/PtNRBs as a versatile platform for the reliable determination of PG and OFL in food and water samples.
- 26 May 2026
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
Unique Dual-Functional and Label-Free Turn-On and Turn-Off Fluorescence Biosensor to Antibiotics Using Hemoglobin-Capped Platinum Nanoribbons: From Reduction-Induced Emission to Inner Filter Effect and Aggregation-Caused Quenching
Distinct from the predominantly known single-functional biosensor, dual-functional response to antibiotics by luminescent nanoribbons remains largely unexplored despite their interesting advantages in enabling self-validation through two independent fluorescence mechanisms. Antibiotic residues in food and environmental matrices pose serious health risks, which emphasizes the urgent need for highly sensitive and reliable detection strategies. Conventional analytical methods, however, often suffer from biological interferences and labor-intensive procedures, thereby underscoring demand for more efficient and robust alternatives. In this study, we focus on the detection of penicillin G (PG) and ofloxacin (OFL), representative members of the β-lactam and fluoroquinolone classes, respectively. Unlike previous reports that mainly targeted a single antibiotic class, we introduce, for the first time, a dual-functional, label-free, protein-capped platinum nanoribbon (Hb/PtNRBs) sensor capable of detecting PG via a fluorescence turn-off mechanism and OFL through a turn-on mechanism. The one-dimensional (1D) porous Pt nanoribbons, exhibiting intense blue fluorescence, were synthesized based on aggregation-induced emission (AIE) in a green, single-step process using hemoglobin (Hb) as both a reducing and capping agent. The Hb/PtNRBs display blue fluorescence with a peak centered at 442 nm (photoexcited at 325 nm) and a quantum yield of 0.25. PG detection occurs through a combination of the inner filter effect (IFE) and aggregation-caused quenching (ACQ), whereas OFL detection is attributed to a reduction-induced emission (RIE) mechanism. Under the optimized conditions, the sensor exhibited wide linear ranges of 0.2-65 μM for PG (LOD = 60 nM) and 0.2-42 μM for OFL (LOD = 45 nM). Practical applicability was confirmed in real samples, including water, cow milk, and eggs, achieving recoveries of 87.25-106.34% for PG and 86.58-120.18% for OFL. These results highlight the high sensitivity, selectivity, and potential of Hb/PtNRBs as a versatile platform for the reliable determination of PG and OFL in food and water samples.
- 2 February 2026
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 9 (4) , 2058-2078
Theranostic Folate-Targeted Doxorubicin-Loaded MIL-88A@CuFe 2 O 4 Nanohybrids, a pH-Sensitive, Core–Shell, Mesoporous Drug Delivery Platform with Dual-Modal T1–T2MRI and Optical Imaging Contrast Properties: An In Vitro and In Vivo Cancer Study
Multifunctional magneto-theranostic nanoplatform, with integrate imaging and therapy in simple platform offer transformative potential for precision cancer management due to their strong magnetic properties, biocompatibility, and versatile theranostic capabilities. Here, we report for the first time the theranostic application of in situ mesoporous core-shell MIL-88A@CuFe2O4 nanohybrid, as an interesting smart platform for dual-mode T1-T2MRI and optical imaging with quantitative analysis, combined with pH-sensitive targeted drug delivery. The nanohybrid was fabricated via a simple in situ synthesis, where Fe (0) from the CuFe2O4 core serves as a Fe3+ source for MIL-88A shell crystallization in the presence of fumaric acid, producing a mesoporous structure with high porosity and strong magnetism. Fe3+ centers in the MIL-88A shell provide T1 contrast, while the CuFe2O4 core enhances both T1 and T2 signals, achieving robust dual-mode MRI (r1 = 73.0 mM-1 s-1, r2 = 700.9 mM-1 s-1). The mesoporous shell allows pH-sensitive controlled release of doxorubicin, and folate conjugation ensures active tumor targeting, while intrinsic doxorubicin fluorescence enables optical tracking of biodistribution in vivo. Comprehensive in vitro and in vivo evaluations demonstrated high biocompatibility, selective cancer cell uptake, effective pH-responsive drug release, dual-modal MRI and fluorescence contrast, and significant tumor growth inhibition in a triple-negative breast cancer (4T1) mouse model. The nanohybrid's combination of high porosity, strong magnetism, dual T1-T2MRI contrast, targeted drug delivery, and therapeutic efficacy distinguish it from existing theranostic agents. This work highlights a theranostic application of MIL-88A@CuFe2O4 nanohybrids, demonstrating their potential as a unique multifunctional platform for precise cancer diagnosis and treatment.
- 2 February 2026
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 9 (4) , 2058-2078
Theranostic Folate-Targeted Doxorubicin-Loaded MIL-88A@CuFe 2 O 4 Nanohybrids, a pH-Sensitive, Core–Shell, Mesoporous Drug Delivery Platform with Dual-Modal T1–T2MRI and Optical Imaging Contrast Properties: An In Vitro and In Vivo Cancer Study
Multifunctional magneto-theranostic nanoplatform, with integrate imaging and therapy in simple platform offer transformative potential for precision cancer management due to their strong magnetic properties, biocompatibility, and versatile theranostic capabilities. Here, we report for the first time the theranostic application of in situ mesoporous core-shell MIL-88A@CuFe2O4 nanohybrid, as an interesting smart platform for dual-mode T1-T2MRI and optical imaging with quantitative analysis, combined with pH-sensitive targeted drug delivery. The nanohybrid was fabricated via a simple in situ synthesis, where Fe (0) from the CuFe2O4 core serves as a Fe3+ source for MIL-88A shell crystallization in the presence of fumaric acid, producing a mesoporous structure with high porosity and strong magnetism. Fe3+ centers in the MIL-88A shell provide T1 contrast, while the CuFe2O4 core enhances both T1 and T2 signals, achieving robust dual-mode MRI (r1 = 73.0 mM-1 s-1, r2 = 700.9 mM-1 s-1). The mesoporous shell allows pH-sensitive controlled release of doxorubicin, and folate conjugation ensures active tumor targeting, while intrinsic doxorubicin fluorescence enables optical tracking of biodistribution in vivo. Comprehensive in vitro and in vivo evaluations demonstrated high biocompatibility, selective cancer cell uptake, effective pH-responsive drug release, dual-modal MRI and fluorescence contrast, and significant tumor growth inhibition in a triple-negative breast cancer (4T1) mouse model. The nanohybrid's combination of high porosity, strong magnetism, dual T1-T2MRI contrast, targeted drug delivery, and therapeutic efficacy distinguish it from existing theranostic agents. This work highlights a theranostic application of MIL-88A@CuFe2O4 nanohybrids, demonstrating their potential as a unique multifunctional platform for precise cancer diagnosis and treatment.
- Open Access
- 11 December 2025
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
3D printed, biodegradable, and biocompatible intraperitoneal implants loaded with folic acid-targeted/pH-sensitive/doxorubicin-loaded hydroxyapatite nanoparticles for systemic treatment of metastatic breast cancer
Three-dimensional porous scaffolds with the capability of controlled drug release have gained increasing interest in chemotherapy due to their sustained re
- 11 December 2025
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Open Access3D printed, biodegradable, and biocompatible intraperitoneal implants loaded with folic acid-targeted/pH-sensitive/doxorubicin-loaded hydroxyapatite nanoparticles for systemic treatment of metastatic breast cancer
Three-dimensional porous scaffolds with the capability of controlled drug release have gained increasing interest in chemotherapy due to their sustained re
- Open Access
- 30 October 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-10
Very simple and ultra-sensitive fluorescence resonance energy transfer aptasensor for turn-on C-reactive protein detection in biological matrices
In the present study, an ultra-sensitive, very simple, and specific fluorescence resonance energy transfer (FRET)-based aptasensor was developed to detect C-reactive protein (CRP). CRP is a critical clinical biomarker and a sensitive indicator of inflammation, tissue damage, and infectious illnesses. Our turn off-on aptasensor system utilizes 6-carboxyfluorescein (5-FAM) dye-labeled aptamer assembled on graphene oxide (GO). The noncovalent assembly between the aptamer and GO initially quenches the fluorescence of the dye through FRET, creating a “turn-off” state. Upon addition of CRP protein, the aptamer binds to CRP, causing the dye to separate from GO, thereby recovering the fluorescence signal and creating a “turn-on” state. Under optimal conditions, the aptasensor exhibits two linear ranges (33–82 fg/ml and 114–207 fg/ml) and an exceptional limit of detection (LOD) of 2.27 fg/ml. This ultra-sensitive aptasensor demonstrates excellent selectivity, as potential interference from other substances was negligible. Compared to other methods, our proposed turn off-on aptasensor-assembled GO offers a more extensive detection range and significantly higher sensitivity. Additionally, it yields satisfactory results by applying 1 µl of real positive and negative serum samples, showcasing its potential for practical applications in clinical diagnostics.
- 30 October 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-10
Open AccessVery simple and ultra-sensitive fluorescence resonance energy transfer aptasensor for turn-on C-reactive protein detection in biological matrices
In the present study, an ultra-sensitive, very simple, and specific fluorescence resonance energy transfer (FRET)-based aptasensor was developed to detect C-reactive protein (CRP). CRP is a critical clinical biomarker and a sensitive indicator of inflammation, tissue damage, and infectious illnesses. Our turn off-on aptasensor system utilizes 6-carboxyfluorescein (5-FAM) dye-labeled aptamer assembled on graphene oxide (GO). The noncovalent assembly between the aptamer and GO initially quenches the fluorescence of the dye through FRET, creating a “turn-off” state. Upon addition of CRP protein, the aptamer binds to CRP, causing the dye to separate from GO, thereby recovering the fluorescence signal and creating a “turn-on” state. Under optimal conditions, the aptasensor exhibits two linear ranges (33–82 fg/ml and 114–207 fg/ml) and an exceptional limit of detection (LOD) of 2.27 fg/ml. This ultra-sensitive aptasensor demonstrates excellent selectivity, as potential interference from other substances was negligible. Compared to other methods, our proposed turn off-on aptasensor-assembled GO offers a more extensive detection range and significantly higher sensitivity. Additionally, it yields satisfactory results by applying 1 µl of real positive and negative serum samples, showcasing its potential for practical applications in clinical diagnostics.
- 8 October 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (41) , 22730-22744
Ratiometric Fluorescence Chiral Sensors for pH Monitoring and Its Applications in Indicator Paper and Bioimaging
Chirality is a prevalent phenomenon in nature and living organisms and plays a significant role in biological systems. The chirality of nanomaterials represents one of the most exciting and rapidly expanding fields of science. Comparing the pH response of enantiomers of a particular chiral species remains a challenge in the field of chemistry. In this work, chiral d/l-Cdots were prepared by post-modifying an achiral Cdots core with arginine enantiomers as chiral ligands for comparing the pH sensitivity of enantiomers. In this case, modified silicon quantum dots (SiQDs) were employed to harness a sensitive and accurate ratiometric method. The fluorescence response of chiral sensors is based on an "on-off" strategy, with different pH ranges for d- and l-probes. Surprisingly, the d- and l-probes show different sensitivities to pH, with a linear range of pH 4.0-8.0 for d-probes and 3.5-7.5 for l-probes. The response mechanism is based on aggregation caused quenching (ACQ) due to protonated-deprotonated d-Cdots/Ca-SiQDs and l-Cdots/Ca-SiQDs probes in acidic and basic environments. Quantum mechanical (QM) calculations were in excellent agreement with the experimental results, confirming the stronger binding affinity of d-Cdots to protonated and aggregation in acidic conditions compared to l-Cdots. Crucially, these chiral probes have been successfully utilized as indicator paper and accurately detect intracellular pH (pHi) in SK-BR-3 breast cancer cells.
- 8 October 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (41) , 22730-22744
Ratiometric Fluorescence Chiral Sensors for pH Monitoring and Its Applications in Indicator Paper and Bioimaging
Chirality is a prevalent phenomenon in nature and living organisms and plays a significant role in biological systems. The chirality of nanomaterials represents one of the most exciting and rapidly expanding fields of science. Comparing the pH response of enantiomers of a particular chiral species remains a challenge in the field of chemistry. In this work, chiral d/l-Cdots were prepared by post-modifying an achiral Cdots core with arginine enantiomers as chiral ligands for comparing the pH sensitivity of enantiomers. In this case, modified silicon quantum dots (SiQDs) were employed to harness a sensitive and accurate ratiometric method. The fluorescence response of chiral sensors is based on an "on-off" strategy, with different pH ranges for d- and l-probes. Surprisingly, the d- and l-probes show different sensitivities to pH, with a linear range of pH 4.0-8.0 for d-probes and 3.5-7.5 for l-probes. The response mechanism is based on aggregation caused quenching (ACQ) due to protonated-deprotonated d-Cdots/Ca-SiQDs and l-Cdots/Ca-SiQDs probes in acidic and basic environments. Quantum mechanical (QM) calculations were in excellent agreement with the experimental results, confirming the stronger binding affinity of d-Cdots to protonated and aggregation in acidic conditions compared to l-Cdots. Crucially, these chiral probes have been successfully utilized as indicator paper and accurately detect intracellular pH (pHi) in SK-BR-3 breast cancer cells.
- 21 October 2024
- Published by Springer Nature in Journal of the Iranian Chemical Society
- Vol. 21 (11) , 2753-2765
Visible-light types I and II N-TiO2-based iron metalloporphyrin for efficient photodynamic therapy
- 21 October 2024
- Published by Springer Nature in Journal of the Iranian Chemical Society
- Vol. 21 (11) , 2753-2765
Visible-light types I and II N-TiO2-based iron metalloporphyrin for efficient photodynamic therapy
- 2 September 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (36) , 48058-48072
Fluorescence and Circular Dichroism Dual-Mode Probe for Chiral Recognition of Tyrosine and Its Applications in Bioimaging
Chiral amino acids (AAs) are essential in metabolism and understanding physiological processes, and they could be used as biomarkers for the diagnosis of different diseases. In this study, chiral Cdots@Van were prepared by postmodifying an achiral Cdots core with vancomycin for recognizing and determining the enantiomeric excess (ee) of tyrosine (Tyr) enantiomers. The fluorescence response of Cdots@Van is based on an "on-off" strategy, with different quenching percentages for d- and l-tyrosine. Interestingly, the circular dichroism (CD) spectrum of Cdots@Van responded to only one form of Tyr enantiomer, specifically d-Tyr, and remained nearly unchanged upon the addition of l-Tyr. Quantum mechanical (QM) calculations were in excellent agreement with the experimental results, confirming the stronger binding affinity of Cdots@Van for d-Tyr compared to l-Tyr. We further investigated the chiral recognition ability of the interconnected vancomycin particles, which was synthesized using the EDC/NHS coupling reaction between vancomycin molecules without a Cdots core. Surprisingly, unlike free vancomycin molecules, interconnected vancomycin displayed an enantiomeric recognition ability by CD spectroscopy, similar to what was observed for Cdots@Van. Crucially, this chiral probe has been successfully utilized for cell imaging applications.
- 2 September 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (36) , 48058-48072
Fluorescence and Circular Dichroism Dual-Mode Probe for Chiral Recognition of Tyrosine and Its Applications in Bioimaging
Chiral amino acids (AAs) are essential in metabolism and understanding physiological processes, and they could be used as biomarkers for the diagnosis of different diseases. In this study, chiral Cdots@Van were prepared by postmodifying an achiral Cdots core with vancomycin for recognizing and determining the enantiomeric excess (ee) of tyrosine (Tyr) enantiomers. The fluorescence response of Cdots@Van is based on an "on-off" strategy, with different quenching percentages for d- and l-tyrosine. Interestingly, the circular dichroism (CD) spectrum of Cdots@Van responded to only one form of Tyr enantiomer, specifically d-Tyr, and remained nearly unchanged upon the addition of l-Tyr. Quantum mechanical (QM) calculations were in excellent agreement with the experimental results, confirming the stronger binding affinity of Cdots@Van for d-Tyr compared to l-Tyr. We further investigated the chiral recognition ability of the interconnected vancomycin particles, which was synthesized using the EDC/NHS coupling reaction between vancomycin molecules without a Cdots core. Surprisingly, unlike free vancomycin molecules, interconnected vancomycin displayed an enantiomeric recognition ability by CD spectroscopy, similar to what was observed for Cdots@Van. Crucially, this chiral probe has been successfully utilized for cell imaging applications.
- 30 May 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (23) , 29581-29599
Bioelectrocatalytic Activity of One-Dimensional Porous Pt Nanoribbons for Efficient Inhibition of Tumor Growth and Metastasis
Designing and synthesizing one-dimensional porous Pt nanocrystals with unique optical, electrocatalytic, and theranostic properties are gaining lots of attention, especially to overcome the challenges of tumor recurrence and resistance to platinum-based chemotherapy. Herein, we represented an interesting report of a one-step and facile strategy for synthesizing multifunctional one-dimensional (1D) porous Pt nanoribbons (PtNRBs) with highly efficient therapeutic effects on cancer cells based on inherent electrocatalytic activity. The critical point in the formation of luminescent porous PtNRBs was the use of human hemoglobin (Hb) as a shape-regulating, stabilizing, and reducing agent with facet-specific domains on which fluorescent platinum nanoclusters at first are aggregated by aggregation-induced emission phenomena (AIE) and then crystallized into contact and penetration twins, as intermediate products, followed by shaping of the final luminescent porous ribbon nanomaterials, owing to oriented attachment association via the Ostwald ripening mechanism. From a medical point of view, the key strategy for effective cancer therapy occured via using low-dosage ethanol in the presence of electroactive porous PtNRBs based on intracellular ethanol oxidation-mediated reactive oxygen species (ROS) generation. The role of heme groups of Hb, as electrocatalytically active centers, was successfully demonstrated in both kinetically controlled anisotropic growth of NRBs for slowing down the reduction of Pt(II) followed by oligomerization of Pt(II)-Hb complexes via platinophilic interactions as well as electrocatalytic ethanol oxidation for therapy. Interestingly, hyaluronic acid-targeted (HA) Hb-PtNRB in the presence of low-dose ethanol caused extraordinary arrest of tumor growth and metastasis with no recurrence even after the treatment course stopped, which caused elongation of tumor-bearing mice survival. HA/Hb-PtNRB was completely biocompatible and exhibited high tumor-targeting efficacy for fluorescent imaging of breast tumors. Therefore, the synergistic electrocatalytic activity of PtNRBs is presented as an efficient and safe cancer theranostic method for the first time.
- 30 May 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (23) , 29581-29599
Bioelectrocatalytic Activity of One-Dimensional Porous Pt Nanoribbons for Efficient Inhibition of Tumor Growth and Metastasis
Designing and synthesizing one-dimensional porous Pt nanocrystals with unique optical, electrocatalytic, and theranostic properties are gaining lots of attention, especially to overcome the challenges of tumor recurrence and resistance to platinum-based chemotherapy. Herein, we represented an interesting report of a one-step and facile strategy for synthesizing multifunctional one-dimensional (1D) porous Pt nanoribbons (PtNRBs) with highly efficient therapeutic effects on cancer cells based on inherent electrocatalytic activity. The critical point in the formation of luminescent porous PtNRBs was the use of human hemoglobin (Hb) as a shape-regulating, stabilizing, and reducing agent with facet-specific domains on which fluorescent platinum nanoclusters at first are aggregated by aggregation-induced emission phenomena (AIE) and then crystallized into contact and penetration twins, as intermediate products, followed by shaping of the final luminescent porous ribbon nanomaterials, owing to oriented attachment association via the Ostwald ripening mechanism. From a medical point of view, the key strategy for effective cancer therapy occured via using low-dosage ethanol in the presence of electroactive porous PtNRBs based on intracellular ethanol oxidation-mediated reactive oxygen species (ROS) generation. The role of heme groups of Hb, as electrocatalytically active centers, was successfully demonstrated in both kinetically controlled anisotropic growth of NRBs for slowing down the reduction of Pt(II) followed by oligomerization of Pt(II)-Hb complexes via platinophilic interactions as well as electrocatalytic ethanol oxidation for therapy. Interestingly, hyaluronic acid-targeted (HA) Hb-PtNRB in the presence of low-dose ethanol caused extraordinary arrest of tumor growth and metastasis with no recurrence even after the treatment course stopped, which caused elongation of tumor-bearing mice survival. HA/Hb-PtNRB was completely biocompatible and exhibited high tumor-targeting efficacy for fluorescent imaging of breast tumors. Therefore, the synergistic electrocatalytic activity of PtNRBs is presented as an efficient and safe cancer theranostic method for the first time.
- 5 March 2024
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 96 (11) , 4377-4384
Microfluidic System Consisting of a Magnetic 3D-Printed Microchannel Filter for Isolation and Enrichment of Circulating Tumor Cells Targeted by Anti-HER2/MOF@Ferrite Core–Shell Nanostructures: A Theranostic CTC Dialysis System
Low number of circulating tumor cells (CTCs) in the blood samples and time-consuming properties of the current CTC isolation methods for processing a small volume of blood are the biggest obstacles to CTC usage in practice. Therefore, we aimed to design a CTC dialysis system with the ability to process cancer patients' whole blood within a reasonable time. Two strategies were employed for developing this dialysis setup, including (i) synthesizing novel in situ core-shell Cu ferrites consisting of the Cu-CuFe2O4 core and the MIL-88A shell, which are targeted by the anti-HER2 antibody for the efficient targeting and trapping of CTCs; and (ii) fabricating a microfluidic system containing a three-dimensional (3D)-printed microchannel filter composed of a polycaprolactone/Fe3O4 nanoparticle composite with pore diameter less than 200 μm on which a high-voltage magnetic field is focused to enrich and isolate the magnetic nanoparticle-targeted CTCs from a large volume of blood. The system was assessed in different aspects including capturing the efficacy of the magnetic nanoparticles, CTC enrichment and isolation from large volumes of human blood, side effects on blood cells, and the viability of CTCs after isolation for further analysis. Under the optimized conditions, the CTC dialysis system exhibited more than 80% efficacy in the isolation of CTCs from blood samples. The isolated CTCs were viable and were able to proliferate. Moreover, the CTC dialysis system was safe and did not cause side effects on normal blood cells. Taken together, the designed CTC dialysis system can process a high volume of blood for efficient dual diagnostic and therapeutic purposes.
- 5 March 2024
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 96 (11) , 4377-4384
Microfluidic System Consisting of a Magnetic 3D-Printed Microchannel Filter for Isolation and Enrichment of Circulating Tumor Cells Targeted by Anti-HER2/MOF@Ferrite Core–Shell Nanostructures: A Theranostic CTC Dialysis System
Low number of circulating tumor cells (CTCs) in the blood samples and time-consuming properties of the current CTC isolation methods for processing a small volume of blood are the biggest obstacles to CTC usage in practice. Therefore, we aimed to design a CTC dialysis system with the ability to process cancer patients' whole blood within a reasonable time. Two strategies were employed for developing this dialysis setup, including (i) synthesizing novel in situ core-shell Cu ferrites consisting of the Cu-CuFe2O4 core and the MIL-88A shell, which are targeted by the anti-HER2 antibody for the efficient targeting and trapping of CTCs; and (ii) fabricating a microfluidic system containing a three-dimensional (3D)-printed microchannel filter composed of a polycaprolactone/Fe3O4 nanoparticle composite with pore diameter less than 200 μm on which a high-voltage magnetic field is focused to enrich and isolate the magnetic nanoparticle-targeted CTCs from a large volume of blood. The system was assessed in different aspects including capturing the efficacy of the magnetic nanoparticles, CTC enrichment and isolation from large volumes of human blood, side effects on blood cells, and the viability of CTCs after isolation for further analysis. Under the optimized conditions, the CTC dialysis system exhibited more than 80% efficacy in the isolation of CTCs from blood samples. The isolated CTCs were viable and were able to proliferate. Moreover, the CTC dialysis system was safe and did not cause side effects on normal blood cells. Taken together, the designed CTC dialysis system can process a high volume of blood for efficient dual diagnostic and therapeutic purposes.